CELL THERAPEUTICS INC | 0,944 Euro | -0,042 -4,26 % | |
| WKN: A1J2YU ISIN: US1509348835 Ticker-Symbol: CEPR | Frankfurt | 24.05.13 | 19:52 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 22.05. | Possible Bearish Inside Day Candle Pattern Detected for Cell Therapeutics | 10 | SmarTrend | |
| 22.05. | Investors look to Lighten Up on Shares of Cell Therapeutics, Shares Down 5.2% | 5 | SmarTrend | |
| 22.05. | Cell Therapeutics, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 02:30 PM | 20 | Seeking Alpha | |
| 15.05. | Cell Therapeutics to Present at Upcoming Investor Conferences | 98 | PR Newswire | |
| SEATTLE, May 15, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the following upcoming investor conferences.... Mehr lesen zu: Cell Therapeutics to Present at Upcoming Investor Conferences | ||||
| 02.05. | Cell Therapeutics' loss widens as it begins selling cancer drug | 30 | bizjournals | |
| 02.05. | CELL THERAPEUTICS INC - 8-K, Current Report | 5 | SEC Filings | |
| 02.05. | Cell Therapeutics Reports First Quarter 2013 Financial Results | 62 | PR Newswire | |
| SEATTLE, May 2, 2013 /PRNewswire/ -- Cell Therapeutics, Inc.(CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2013.
"In the first quarter, we generated... Mehr lesen zu: Cell Therapeutics Reports First Quarter 2013 Financial Results | ||||
| 24.04. | Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013 | 107 | PR Newswire | |
| SEATTLE, April 24, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter financial results on Thursday, May... Mehr lesen zu: Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013 | ||||
| 18.04. | Cell Therapeutics: Addicted to Reverse Stock Splits | 22 | The Street | |
| 05.04. | Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics | 241 | PR Newswire | |
| LONDON, April 5, 2013 /PRNewswire/ --
Swiss pharmaceutical major Novartis AG recently lost a patent case related to its cancer drug in India. The development once again highlights that drug manufacturers... Mehr lesen zu: Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics | ||||
| 29.03. | Cell Therapeutics stock rebounds after news of $15M loan | 13 | bizjournals | |
| 28.03. | Hot Stock: Cell Therapeutics, Shares Gain 11.5% | 5 | SmarTrend | |
| 28.03. | Cell Therapeutics gets $15M loan | 5 | bizjournals | |
| 28.03. | Cell Therapeutics (CTIC) Moves Higher After Securing $15M in Financing | 4 | StreetInsider.com | |
| 28.03. | Cell Therapeutics Enters $15M Loan Financing Agreement with Hercules Technology Growth Capital | 2 | Benzinga.com | |
| 28.03. | Cell Therapeutics Inks $15 Mln Loan Agreement With Hercules Technology | 88 | AFX News | |
| WASHINGTON (dpa-AFX) - Cell Therapeutics, Inc. (CTIC) Thursday announced a
loan agreement with Hercules Technology Growth Capital, Inc. or HTGC, providing
for a senior secured term loan... Mehr lesen zu: Cell Therapeutics Inks $15 Mln Loan Agreement With Hercules Technology | ||||
| 28.03. | Cell Therapeutics Secures $15 Million Loan Financing Agreement | 65 | PR Newswire | |
| SEATTLE, March 28, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE:... Mehr lesen zu: Cell Therapeutics Secures $15 Million Loan Financing Agreement | ||||
| 25.03. | Stock to Watch: Cell Therapeutics Down 6.9% | 24 | SmarTrend | |
| 14.03. | Biotech Industry Looks to Benefit From FDA's New "Breakthrough" Designation / Five Star Equities Provides Stock Research on Cell Therapeutics and Santarus | 104 | Marketwired | |
| NEW YORK, NY -- (Marketwire) -- 03/14/13 -- Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry.... Mehr lesen zu: Biotech Industry Looks to Benefit From FDA's New "Breakthrough" Designation / Five Star Equities Provides Stock Research on Cell Therapeutics and Santarus | ||||
| 11.03. | Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference | 129 | PR Newswire | |
| SEATTLE, March 11, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the ROTH Capital Partners 25th Annual Growth Stock Conference... Mehr lesen zu: Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MEDIGENE | 0,93 | +4,61 % | Medigene: Rating wird erneuert |
| AGENNIX | 0,07 | -27,08 % | Agennix AG gibt Liquidation bekannt |
| EVOTEC | 2,75 | -0,58 % | Evotec-Aktie: Jetzt einsteigen! |
| ANTISOMA | 0,017 | 0 % | Antisoma PLC: TR1 Notification of major interest in shares |
| GERON | 0,851 | -0,35 % | GERON CORP - 8-K, Current Report |
